BDNF and GDNF serum levels in alcohol-dependent patients during withdrawal

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 34, Issue 6, 2010, Pages 1060-1064

  Heberlein, Annemarie ^a,b   Muschler, Marc ^a   Wilhelm, Julia ^a,b   Frieling, Helge ^a,b   Lenz, Bernd ^b   Gröschl, Michael ^b   Kornhuber, Johannes ^b   Bleich, Stefan ^a,b   Hillemacher, Thomas ^a,b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Alcohol dependence; Alcohol withdrawal; BDNF; Craving; GDNF; Neurotrophic growth factors

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CLOMETHIAZOLE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; OXCARBAZEPINE; PROMETHAZINE;

ADULT; ALCOHOL TOLERANCE; ALCOHOL WITHDRAWAL; ALCOHOLISM; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; PROTEIN DEPLETION; PSYCHOMETRY; ALCOHOL ABSTINENCE; ANALYSIS OF VARIANCE; BLOOD; MIDDLE AGED; PROSPECTIVE STUDY; WITHDRAWAL SYNDROME;

ADULT; ALCOHOLISM; ANALYSIS OF VARIANCE; BRAIN-DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SUBSTANCE WITHDRAWAL SYNDROME; TEMPERANCE;

EID: 77955049283     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2010.05.025     Document Type: Article

References (31)

1. Airaksinen M.S., Saarma M. The GDNF family: signalling, biological functions and therapeutic value. Nat. Rev. Neurosci. 2002, 3:383-394.
2. Akaneya Y., Takahashi M., Hatanaka H. Selective acid vulnerability of dopaminergic neurons and its recovery by brain-derived neurotrophic factor. Brain Res. 1995, 704:175-183.
3. Altar C.A., Boylan C.B., Fritsche M., Jackson C., Hyman C., Lindsay R.M. The neurotrophins NT-4/5 and BDNF augment serotonin, dopamine, and GABAergic systems during behaviorally effective infusions to the substantia nigra. Exp. Neurol. 1994, 130:31-40.
4. Altar C.A., Boylan C.B., Jackson C., Hershenson S., Miller J., Wiegand S.J., Lindsay R.M., Hyman C. Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:11347-11351.
5. Anton R.F., Moak D.H., Latham P. The Obsessive Compulsive Drinking Scale: a self-rated instrument for the quantification of thoughts about alcohol and drinking behavior. Alcohol. Clin. Exp. Res. 1995, 19:92-99.
6. Beck A.T., H W.C., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatry 1961, 4:561-571.
7. Carnicella S., Ahmadiantehrani S., Janak P.H., Ron D. GDNF is an endogenous negative regulator of ethanol-mediated reward and of ethanol consumption after a period of abstinence. Alcohol. Clin. Exp. Res. 2009, 33:1012-1024.
8. Carnicella S., Kharazia V., Jeanblanc J., Janak P.H., Ron D. GDNF is a fast-acting potent inhibitor of alcohol consumption and relapse. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:8114-8119.
9. Chang Y.C., Rapoport S.I., Rao J.S. Chronic administration of mood stabilizers upregulates BDNF and bcl-2 expression levels in rat frontal cortex. Neurochem. Res. 2009, 34:536-541.
10. Chao M.V., Rajagopal R., Lee F.S. Neurotrophin signalling in health and disease. Clin. Sci. (Lond) 2006, 110:167-173.
11. Choudhry M.A., Chaudry I.H. Alcohol, burn injury, and the intestine. J. Emerg. Trauma Shock 2008, 1:81-87.
12. Cirulli F., Francia N., Branchi I., Antonucci M.T., Aloe L., Suomi S.J., Alleva E. Changes in plasma levels of BDNF and NGF reveal a gender-selective vulnerability to early adversity in rhesus macaques. Psychoneuroendocrinology 2009, 34:172-180.
13. Corominas M., Roncero C., Ribases M., Castells X., Casas M. Brain-derived neurotrophic factor and its intracellular signaling pathways in cocaine addiction. Neuropsychobiology 2007, 55:2-13.
14. Heberlein A., Lenz B., et al. BDNF plasma levels decrease during benzodiazepine withdrawal in patients suffering from comorbidity of depressive disorder and benzodiazepine dependence. Psychopharmacol 2010, 209(2):213.
15. Heberlein A., Muschler M.A., et al. Serum levels of Vascular Endothelial Growth Factor A increase during alcohol withdrawal. Addict Biol. 2010, 15:362-364.
16. Huang M.C., Chen C.H., Chen C.H., Liu S.C., Ho C.J., Shen W.W., Leu S.J. Alterations of serum brain-derived neurotrophic factor levels in early alcohol withdrawal. Alcohol Alcohol. 2008, 43:241-245.
17. Jeanblanc J., He D.Y., McGough N.N., Logrip M.L., Phamluong K., Janak P.H., Ron D. The dopamine D3 receptor is part of a homeostatic pathway regulating ethanol consumption. J. Neurosci. 2006, 26:1457-1464.
18. Joe K.H., Kim Y.K., Kim T.S., Roh S.W., Choi S.W., Kim Y.B., Lee H.J., Kim D.J. Decreased plasma brain-derived neurotrophic factor levels in patients with alcohol dependence. Alcohol. Clin. Exp. Res. 2007, 31:1833-1838.
19. John U., Hapke U., Rumpf H.J. A new measure of the alcohol dependence syndrome: the severity scale of alcohol dependence. Eur. Addict. Res. 2003, 9:87-93.
20. Lee B.C., Choi I.G., Kim Y.K., Ham B.J., Yang B.H., Roh S., Choi J., Lee J.S., Oh D.Y., Chai Y.G. Relation between plasma brain-derived neurotrophic factor and nerve growth factor in the male patients with alcohol dependence. Alcohol 2009, 43:265-269.
21. Lee B.H., Kim Y.K. Reduced platelet BDNF level in patients with major depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009, 33:849-853.
22. Logrip M.L., Janak P.H., Ron D. Escalating ethanol intake is associated with altered corticostriatal BDNF expression. J. Neurochem. 2009, 109:1459-1468.
23. Lommatzsch M., Quarcoo D., Schulte-Herbruggen O., Weber H., Virchow J.C., Renz H., Braun A. Neurotrophins in murine viscera: a dynamic pattern from birth to adulthood. Int. J. Dev. Neurosci. 2005, 23:495-500.
24. Mayfield D., McLeod G., Hall P. The CAGE questionnaire: validation of a new alcoholism screening instrument. Am. J. Psychiatry 1974, 131:1121-1123.
25. McGough N.N., He D.Y., Logrip M.L., Jeanblanc J., Phamluong K., Luong K., Kharazia V., Janak P.H., Ron D. RACK1 and brain-derived neurotrophic factor: a homeostatic pathway that regulates alcohol addiction. J. Neurosci. 2004, 24:10542-10552.
26. Pierce R.C., Kumaresan V. The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse?. Neurosci. Biobehav. Rev. 2006, 30:215-238.
27. Ron D., Janak P.H. GDNF and addiction. Rev. Neurosci. 2005, 16:277-285.
28. Saunders J.B., Aasland O.G., Babor T.F., de la Fuente J.R., Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption-II. Addiction 1993, 88:791-804.
29. Spielberger C.D., Gorusch R.L., Lushene R.E. STAI Manual 1970, Consulting Psychologists Press, Inc., Consulting Psychologists Press, Inc.
30. Sullivan J.T., Sykora K., Schneiderman J., Naranjo C.A., Sellers E.M. Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br. J. Addict. 1989, 84:1353-1357.
31. Takebayashi M., Hisaoka K., Nishida A., Tsuchioka M., Miyoshi I., Kozuru T., Hikasa S., Okamoto Y., Shinno H., Morinobu S., Yamawaki S. Decreased levels of whole blood glial cell line-derived neurotrophic factor (GDNF) in remitted patients with mood disorders. Int. J. Neuropsychopharmacol. 2006, 9:607-612.